| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 1,565,061 | 2,136,882 | 1,988,500 | | Cost of Revenue | 394,825 | 566,534 | 419,808 | | | Gross Profit | 1,170,236 | 1,570,348 | 1,568,692 | | | Operating Expenses | | Research Development | 743,673 | 184,735 | 143,596 | | Selling General and Administrative | 446,020 | 691,034 | 713,965 | | Non Recurring | 49,475 | 293,203 | 161,036 | | Others | 150,713 | 173,863 | 147,549 | | | | Total Operating Expenses | 1,389,881 | 1,342,835 | 1,166,146 | | | | Operating Income or Loss | (219,645) | 227,513 | 402,546 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 25,884 | 31,123 | 31,623 | | Earnings Before Interest And Taxes | (193,761) | 258,636 | 434,169 | | Interest Expense | 7,943 | 7,818 | 9,857 | | Income Before Tax | (201,704) | 250,818 | 424,312 | | Income Tax Expense | 131,359 | 67,600 | 135,730 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (333,063) | 183,218 | 288,582 | | | Non-recurring Events | | Discontinued Operations |
-
| (237) | 367 | | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (333,063) | 182,981 | 288,949 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($333,063) | $182,981 | $288,949 |
|
0.07% Nasdaq 
0.12 (0.99%) 
Income Statement
